Archives

by in
Entry Author Date Location
Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal With Pfizer 12/17/09 Boston
Roche Scraps Partnership With Seattle Genetics on Lymphoma Drug 12/11/09 Seattle
Dendreon Grasps for $400M, ZymoGenetics Cuts 52 Jobs, Calistoga Advances at ASH, & More Seattle-Area Life Sciences News 12/10/09 Seattle
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone 12/09/09 Boston
Seattle Genetics, Genentech Lymphoma Drug Passes Early Test with “Naked” Antibody 12/07/09 Seattle
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore 11/19/09 Boston
Calistoga Cancer Drug Shows “Encouraging” Preliminary Results in Small Study 10/19/09 Seattle
Seattle Genetics Shares Drop on Halted Lymphoma Trial 10/05/09 Seattle
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed 08/12/09 Seattle
Biogen Idec, Trying to Go Beyond Rituxan, Assembles Cancer Drug Pipeline 07/16/09 Boston
Agios Lands Genentech Cancer Drug Leader as New CEO 05/27/09 Boston
How to Raise $50M in a Recession: Highlights from the Xconomy Life Sciences Forum 05/01/09 Boston
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS 03/27/09 Boston
Trubion Starts Lupus Trial 03/25/09 Seattle
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys 03/11/09 Boston
Trubion Cuts One-Fourth of Workforce 02/25/09 Seattle
Pfizer’s Bid For Wyeth Sends Ripples Through Trubion Pharmaceuticals, Seattle Biotechs 01/27/09 Seattle
Biogen Idec VC Group Sees Opportunity in Tough Market, Has $100M New Allocation to Invest in Biotech Firms 12/12/08 San Diego
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting 12/06/08 Seattle
Biogen Pays $31.5M to Genentech to Co-Develop Anti-CD20 Drug 11/03/08 Boston
Trubion Shares Leap, Drop, Leap Again After Encouraging Clinical Trial News 10/27/08 Seattle
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher 10/08/08 Seattle
Trubion Wins Patent Dispute With Genentech, Biogen Idec 09/11/08 Seattle
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug 09/08/08 Seattle
Discovery: The Soul of Biotech, the Place For True Believers, and a Retro Way to Bring it Back 09/08/08 Seattle
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA 09/03/08 Seattle
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors 08/26/08 Seattle
The Future of Biotech Is in Rabbits, Says Entrepreneur Johnny Stine 07/30/08 Seattle
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche 07/22/08 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.